Committees:
- Human Resources and Compensation (Chair)
- Finance
Attributes and Skills Provided to the Board:
- Leadership experience in life sciences and healthcare companies
- Risk management and investment stewardship experience
- Operational experience in capital-intensive, innovation-focused industries
- Growth strategies and market expansion
- Mergers & acquisitions / integrations
- Leadership and talent development
Expertise Provided to the Board:
As a Managing Director at AngelHealthcare Investors, an early-stage angel investment group focused on medical devices, life sciences and pharmaceutical companies, Robyn C. Davis brings valuable investor-focused perspective to the Azenta Board and its ongoing efforts to maximize shareholder value. She also has strong financial acumen, particularly as it relates to operational matters, and extensive experience supporting life sciences companies as they scale and grow, both organically and through mergers and acquisitions, having successfully exited certain portfolio companies and having sat on the Board of CRA Health when it was acquired by Volpara. She has more than three decades of independent C-suite consulting experience with both corporate and non-governmental organizations helping to lead value-creation strategies in growth, cost reduction, leadership and talent development. Ms. Davis also serves on the Boards of Psychemedics Corporation (NASDAQ: PMD), a developer of diagnostic tests, and Akston Biosciences Corporation, a manufacturer of veterinary protein therapeutics.